nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP3A4—Fingolimod—multiple sclerosis	0.0772	0.246	CbGbCtD
Rifabutin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0497	0.158	CbGbCtD
Rifabutin—CYP3A4—Triamcinolone—multiple sclerosis	0.0377	0.12	CbGbCtD
Rifabutin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0363	0.116	CbGbCtD
Rifabutin—HSP90AA1—pons—multiple sclerosis	0.0334	0.206	CbGeAlD
Rifabutin—CYP3A4—Betamethasone—multiple sclerosis	0.0323	0.103	CbGbCtD
Rifabutin—CYP3A4—Prednisolone—multiple sclerosis	0.0319	0.102	CbGbCtD
Rifabutin—CYP3A4—Prednisone—multiple sclerosis	0.0301	0.0959	CbGbCtD
Rifabutin—HSP90AA1—pineal body—multiple sclerosis	0.0238	0.147	CbGeAlD
Rifabutin—CYP3A4—Dexamethasone—multiple sclerosis	0.0188	0.0599	CbGbCtD
Rifabutin—HSP90B1—brainstem—multiple sclerosis	0.0102	0.0628	CbGeAlD
Rifabutin—HSP90B1—retina—multiple sclerosis	0.0098	0.0606	CbGeAlD
Rifabutin—HSP90AA1—brainstem—multiple sclerosis	0.00743	0.0459	CbGeAlD
Rifabutin—HSP90AA1—retina—multiple sclerosis	0.00717	0.0443	CbGeAlD
Rifabutin—HSP90B1—medulla oblongata—multiple sclerosis	0.00708	0.0438	CbGeAlD
Rifabutin—HSP90B1—midbrain—multiple sclerosis	0.00647	0.04	CbGeAlD
Rifabutin—HSP90B1—spinal cord—multiple sclerosis	0.00632	0.0391	CbGeAlD
Rifabutin—HSP90B1—nervous system—multiple sclerosis	0.00532	0.0329	CbGeAlD
Rifabutin—HSP90AA1—medulla oblongata—multiple sclerosis	0.00518	0.032	CbGeAlD
Rifabutin—HSP90B1—central nervous system—multiple sclerosis	0.00512	0.0317	CbGeAlD
Rifabutin—HSP90B1—cerebellum—multiple sclerosis	0.00501	0.031	CbGeAlD
Rifabutin—HSP90AA1—midbrain—multiple sclerosis	0.00473	0.0293	CbGeAlD
Rifabutin—HSP90AA1—spinal cord—multiple sclerosis	0.00462	0.0286	CbGeAlD
Rifabutin—HSP90B1—brain—multiple sclerosis	0.00407	0.0252	CbGeAlD
Rifabutin—HSP90AA1—nervous system—multiple sclerosis	0.00389	0.0241	CbGeAlD
Rifabutin—HSP90AA1—central nervous system—multiple sclerosis	0.00375	0.0232	CbGeAlD
Rifabutin—HSP90AA1—cerebellum—multiple sclerosis	0.00366	0.0226	CbGeAlD
Rifabutin—HSP90AA1—brain—multiple sclerosis	0.00297	0.0184	CbGeAlD
Rifabutin—CYP3A4—nervous system—multiple sclerosis	0.000911	0.00563	CbGeAlD
Rifabutin—CYP3A4—central nervous system—multiple sclerosis	0.000877	0.00542	CbGeAlD
Rifabutin—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000831	0.00268	CcSEcCtD
Rifabutin—Insomnia—Cladribine—multiple sclerosis	0.000825	0.00266	CcSEcCtD
Rifabutin—Paraesthesia—Cladribine—multiple sclerosis	0.000819	0.00264	CcSEcCtD
Rifabutin—Leukopenia—Azathioprine—multiple sclerosis	0.000814	0.00262	CcSEcCtD
Rifabutin—Dyspnoea—Cladribine—multiple sclerosis	0.000813	0.00262	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.00081	0.00261	CcSEcCtD
Rifabutin—Decreased appetite—Cladribine—multiple sclerosis	0.000793	0.00256	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000788	0.00254	CcSEcCtD
Rifabutin—Bronchospasm—Methylprednisolone—multiple sclerosis	0.000781	0.00252	CcSEcCtD
Rifabutin—Pain—Cladribine—multiple sclerosis	0.00078	0.00252	CcSEcCtD
Rifabutin—Arthralgia—Azathioprine—multiple sclerosis	0.000774	0.0025	CcSEcCtD
Rifabutin—Myalgia—Azathioprine—multiple sclerosis	0.000774	0.0025	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000769	0.00248	CcSEcCtD
Rifabutin—Feeling abnormal—Cladribine—multiple sclerosis	0.000752	0.00242	CcSEcCtD
Rifabutin—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000746	0.00241	CcSEcCtD
Rifabutin—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000726	0.00234	CcSEcCtD
Rifabutin—Abdominal pain—Cladribine—multiple sclerosis	0.000721	0.00233	CcSEcCtD
Rifabutin—Body temperature increased—Cladribine—multiple sclerosis	0.000721	0.00233	CcSEcCtD
Rifabutin—Skin disorder—Azathioprine—multiple sclerosis	0.000721	0.00232	CcSEcCtD
Rifabutin—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00072	0.00232	CcSEcCtD
Rifabutin—Anaemia—Mitoxantrone—multiple sclerosis	0.000679	0.00219	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000676	0.00218	CcSEcCtD
Rifabutin—Hypersensitivity—Cladribine—multiple sclerosis	0.000672	0.00217	CcSEcCtD
Rifabutin—Leukopenia—Mitoxantrone—multiple sclerosis	0.000658	0.00212	CcSEcCtD
Rifabutin—Asthenia—Cladribine—multiple sclerosis	0.000655	0.00211	CcSEcCtD
Rifabutin—Pruritus—Cladribine—multiple sclerosis	0.000645	0.00208	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000642	0.00207	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00064	0.00207	CcSEcCtD
Rifabutin—Convulsion—Mitoxantrone—multiple sclerosis	0.000637	0.00205	CcSEcCtD
Rifabutin—Myalgia—Mitoxantrone—multiple sclerosis	0.000626	0.00202	CcSEcCtD
Rifabutin—Arthralgia—Mitoxantrone—multiple sclerosis	0.000626	0.00202	CcSEcCtD
Rifabutin—Chest pain—Mitoxantrone—multiple sclerosis	0.000626	0.00202	CcSEcCtD
Rifabutin—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000624	0.00201	CcSEcCtD
Rifabutin—Diarrhoea—Cladribine—multiple sclerosis	0.000624	0.00201	CcSEcCtD
Rifabutin—Feeling abnormal—Azathioprine—multiple sclerosis	0.000611	0.00197	CcSEcCtD
Rifabutin—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000607	0.00196	CcSEcCtD
Rifabutin—Confusional state—Mitoxantrone—multiple sclerosis	0.000605	0.00195	CcSEcCtD
Rifabutin—Eye disorder—Methylprednisolone—multiple sclerosis	0.000594	0.00192	CcSEcCtD
Rifabutin—Shock—Mitoxantrone—multiple sclerosis	0.00059	0.0019	CcSEcCtD
Rifabutin—Neutropenia—Prednisone—multiple sclerosis	0.000588	0.0019	CcSEcCtD
Rifabutin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000587	0.00189	CcSEcCtD
Rifabutin—Abdominal pain—Azathioprine—multiple sclerosis	0.000586	0.00189	CcSEcCtD
Rifabutin—Body temperature increased—Azathioprine—multiple sclerosis	0.000586	0.00189	CcSEcCtD
Rifabutin—Skin disorder—Mitoxantrone—multiple sclerosis	0.000583	0.00188	CcSEcCtD
Rifabutin—Vomiting—Cladribine—multiple sclerosis	0.00058	0.00187	CcSEcCtD
Rifabutin—Rash—Cladribine—multiple sclerosis	0.000575	0.00186	CcSEcCtD
Rifabutin—Dermatitis—Cladribine—multiple sclerosis	0.000575	0.00185	CcSEcCtD
Rifabutin—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000574	0.00185	CcSEcCtD
Rifabutin—Anorexia—Mitoxantrone—multiple sclerosis	0.000572	0.00184	CcSEcCtD
Rifabutin—Headache—Cladribine—multiple sclerosis	0.000572	0.00184	CcSEcCtD
Rifabutin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000547	0.00176	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000546	0.00176	CcSEcCtD
Rifabutin—Dysgeusia—Triamcinolone—multiple sclerosis	0.000543	0.00175	CcSEcCtD
Rifabutin—Nausea—Cladribine—multiple sclerosis	0.000542	0.00175	CcSEcCtD
Rifabutin—Eye disorder—Dexamethasone—multiple sclerosis	0.00054	0.00174	CcSEcCtD
Rifabutin—Eye disorder—Betamethasone—multiple sclerosis	0.00054	0.00174	CcSEcCtD
Rifabutin—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000538	0.00174	CcSEcCtD
Rifabutin—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000535	0.00172	CcSEcCtD
Rifabutin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000528	0.0017	CcSEcCtD
Rifabutin—Convulsion—Prednisolone—multiple sclerosis	0.000522	0.00168	CcSEcCtD
Rifabutin—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000521	0.00168	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—multiple sclerosis	0.00052	0.00168	CcSEcCtD
Rifabutin—Pain—Mitoxantrone—multiple sclerosis	0.000513	0.00165	CcSEcCtD
Rifabutin—Diarrhoea—Azathioprine—multiple sclerosis	0.000508	0.00164	CcSEcCtD
Rifabutin—Pancytopenia—Methotrexate—multiple sclerosis	0.000499	0.00161	CcSEcCtD
Rifabutin—Connective tissue disorder—Prednisone—multiple sclerosis	0.000495	0.00159	CcSEcCtD
Rifabutin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000494	0.00159	CcSEcCtD
Rifabutin—Neutropenia—Methotrexate—multiple sclerosis	0.000491	0.00158	CcSEcCtD
Rifabutin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00049	0.00158	CcSEcCtD
Rifabutin—Shock—Prednisolone—multiple sclerosis	0.000484	0.00156	CcSEcCtD
Rifabutin—Convulsion—Triamcinolone—multiple sclerosis	0.00048	0.00155	CcSEcCtD
Rifabutin—Convulsion—Methylprednisolone—multiple sclerosis	0.000479	0.00155	CcSEcCtD
Rifabutin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000474	0.00153	CcSEcCtD
Rifabutin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000474	0.00153	CcSEcCtD
Rifabutin—Myalgia—Triamcinolone—multiple sclerosis	0.000472	0.00152	CcSEcCtD
Rifabutin—Vomiting—Azathioprine—multiple sclerosis	0.000472	0.00152	CcSEcCtD
Rifabutin—Myalgia—Methylprednisolone—multiple sclerosis	0.000471	0.00152	CcSEcCtD
Rifabutin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000471	0.00152	CcSEcCtD
Rifabutin—Eye disorder—Prednisone—multiple sclerosis	0.00047	0.00152	CcSEcCtD
Rifabutin—Rash—Azathioprine—multiple sclerosis	0.000468	0.00151	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000468	0.00151	CcSEcCtD
Rifabutin—Dermatitis—Azathioprine—multiple sclerosis	0.000467	0.00151	CcSEcCtD
Rifabutin—Headache—Azathioprine—multiple sclerosis	0.000465	0.0015	CcSEcCtD
Rifabutin—Confusional state—Methylprednisolone—multiple sclerosis	0.000455	0.00147	CcSEcCtD
Rifabutin—Immune system disorder—Prednisone—multiple sclerosis	0.000455	0.00147	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—MMP9—multiple sclerosis	0.000452	0.00211	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PTPRC—multiple sclerosis	0.000448	0.00209	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CCR2—multiple sclerosis	0.000448	0.00209	CbGpPWpGaD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000446	0.00208	CbGpPWpGaD
Rifabutin—Shock—Triamcinolone—multiple sclerosis	0.000445	0.00144	CcSEcCtD
Rifabutin—Insomnia—Prednisolone—multiple sclerosis	0.000445	0.00144	CcSEcCtD
Rifabutin—Shock—Methylprednisolone—multiple sclerosis	0.000444	0.00143	CcSEcCtD
Rifabutin—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000443	0.00143	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—TLR4—multiple sclerosis	0.000442	0.00206	CbGpPWpGaD
Rifabutin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000442	0.00143	CcSEcCtD
Rifabutin—Paraesthesia—Prednisolone—multiple sclerosis	0.000442	0.00142	CcSEcCtD
Rifabutin—Nausea—Azathioprine—multiple sclerosis	0.000441	0.00142	CcSEcCtD
Rifabutin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000438	0.00141	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—CD80—multiple sclerosis	0.000438	0.00204	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—PRNP—multiple sclerosis	0.000437	0.00204	CbGpPWpGaD
Rifabutin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000437	0.00141	CcSEcCtD
Rifabutin—Convulsion—Dexamethasone—multiple sclerosis	0.000436	0.00141	CcSEcCtD
Rifabutin—Convulsion—Betamethasone—multiple sclerosis	0.000436	0.00141	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HLA-DPB1—multiple sclerosis	0.000433	0.00202	CbGpPWpGaD
Rifabutin—Asthenia—Mitoxantrone—multiple sclerosis	0.00043	0.00139	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—SRM—multiple sclerosis	0.00043	0.00201	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MYC—multiple sclerosis	0.000429	0.002	CbGpPWpGaD
Rifabutin—Myalgia—Betamethasone—multiple sclerosis	0.000428	0.00138	CcSEcCtD
Rifabutin—Myalgia—Dexamethasone—multiple sclerosis	0.000428	0.00138	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—P2RX7—multiple sclerosis	0.000421	0.00197	CbGpPWpGaD
Rifabutin—Pain—Prednisolone—multiple sclerosis	0.000421	0.00136	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—multiple sclerosis	0.000421	0.00136	CcSEcCtD
Rifabutin—HSP90B1—Immune System—ITGA4—multiple sclerosis	0.000417	0.00195	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD40—multiple sclerosis	0.000417	0.00195	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IFNB1—multiple sclerosis	0.000414	0.00193	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000412	0.00133	CcSEcCtD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—MAPK1—multiple sclerosis	0.000412	0.00192	CbGpPWpGaD
Rifabutin—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000412	0.00192	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000411	0.00133	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CTLA4—multiple sclerosis	0.000411	0.00192	CbGpPWpGaD
Rifabutin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00041	0.00132	CcSEcCtD
Rifabutin—Insomnia—Triamcinolone—multiple sclerosis	0.000409	0.00132	CcSEcCtD
Rifabutin—Insomnia—Methylprednisolone—multiple sclerosis	0.000408	0.00132	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CD80—multiple sclerosis	0.000408	0.0019	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	0.000408	0.0019	CbGpPWpGaD
Rifabutin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000406	0.00131	CcSEcCtD
Rifabutin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000405	0.00131	CcSEcCtD
Rifabutin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000405	0.00131	CcSEcCtD
Rifabutin—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000405	0.00189	CbGpPWpGaD
Rifabutin—Anaemia—Prednisone—multiple sclerosis	0.000405	0.00131	CcSEcCtD
Rifabutin—Shock—Betamethasone—multiple sclerosis	0.000404	0.0013	CcSEcCtD
Rifabutin—Shock—Dexamethasone—multiple sclerosis	0.000404	0.0013	CcSEcCtD
Rifabutin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000403	0.0013	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—CD80—multiple sclerosis	0.000403	0.00188	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000402	0.0013	CcSEcCtD
Rifabutin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000402	0.0013	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—NOD1—multiple sclerosis	0.0004	0.00187	CbGpPWpGaD
Rifabutin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000398	0.00128	CcSEcCtD
Rifabutin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000397	0.00128	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—multiple sclerosis	0.000393	0.00127	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CD226—multiple sclerosis	0.000392	0.00183	CbGpPWpGaD
Rifabutin—Anorexia—Betamethasone—multiple sclerosis	0.000391	0.00126	CcSEcCtD
Rifabutin—Anorexia—Dexamethasone—multiple sclerosis	0.000391	0.00126	CcSEcCtD
Rifabutin—Pain—Triamcinolone—multiple sclerosis	0.000387	0.00125	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—MALT1—multiple sclerosis	0.000386	0.0018	CbGpPWpGaD
Rifabutin—Vomiting—Mitoxantrone—multiple sclerosis	0.000381	0.00123	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—multiple sclerosis	0.00038	0.00123	CcSEcCtD
Rifabutin—Convulsion—Prednisone—multiple sclerosis	0.00038	0.00122	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—HLA-DRB4—multiple sclerosis	0.000379	0.00177	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000379	0.00177	CbGpPWpGaD
Rifabutin—Rash—Mitoxantrone—multiple sclerosis	0.000378	0.00122	CcSEcCtD
Rifabutin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000378	0.00122	CcSEcCtD
Rifabutin—Headache—Mitoxantrone—multiple sclerosis	0.000376	0.00121	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000374	0.00121	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000374	0.00121	CcSEcCtD
Rifabutin—Arthralgia—Prednisone—multiple sclerosis	0.000373	0.0012	CcSEcCtD
Rifabutin—Myalgia—Prednisone—multiple sclerosis	0.000373	0.0012	CcSEcCtD
Rifabutin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000373	0.0012	CcSEcCtD
Rifabutin—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000373	0.00174	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000373	0.00174	CbGpPWpGaD
Rifabutin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000372	0.0012	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—MAPK1—multiple sclerosis	0.000372	0.00174	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000372	0.00174	CbGpPWpGaD
Rifabutin—Insomnia—Dexamethasone—multiple sclerosis	0.000371	0.0012	CcSEcCtD
Rifabutin—Insomnia—Betamethasone—multiple sclerosis	0.000371	0.0012	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00037	0.00119	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—TYK2—multiple sclerosis	0.00037	0.00173	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000369	0.00119	CcSEcCtD
Rifabutin—Paraesthesia—Betamethasone—multiple sclerosis	0.000369	0.00119	CcSEcCtD
Rifabutin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000369	0.00119	CcSEcCtD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000367	0.00172	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000367	0.00172	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IFIH1—multiple sclerosis	0.000363	0.0017	CbGpPWpGaD
Rifabutin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000362	0.00117	CcSEcCtD
Rifabutin—HSP90B1—Immune System—VCAM1—multiple sclerosis	0.000362	0.00169	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HLA-DQA1—multiple sclerosis	0.000362	0.00169	CbGpPWpGaD
Rifabutin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000361	0.00117	CcSEcCtD
Rifabutin—Dyspepsia—Betamethasone—multiple sclerosis	0.000361	0.00117	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—multiple sclerosis	0.000359	0.00116	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CIITA—multiple sclerosis	0.000358	0.00167	CbGpPWpGaD
Rifabutin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000358	0.00115	CcSEcCtD
Rifabutin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000357	0.00115	CcSEcCtD
Rifabutin—Decreased appetite—Betamethasone—multiple sclerosis	0.000357	0.00115	CcSEcCtD
Rifabutin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000357	0.00115	CcSEcCtD
Rifabutin—Nausea—Mitoxantrone—multiple sclerosis	0.000356	0.00115	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000354	0.00114	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000354	0.00114	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNF—multiple sclerosis	0.000354	0.00165	CbGpPWpGaD
Rifabutin—Shock—Prednisone—multiple sclerosis	0.000352	0.00113	CcSEcCtD
Rifabutin—Pain—Dexamethasone—multiple sclerosis	0.000351	0.00113	CcSEcCtD
Rifabutin—Pain—Betamethasone—multiple sclerosis	0.000351	0.00113	CcSEcCtD
Rifabutin—Skin disorder—Prednisone—multiple sclerosis	0.000347	0.00112	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—TYK2—multiple sclerosis	0.000344	0.00161	CbGpPWpGaD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000344	0.00161	CbGpPWpGaD
Rifabutin—Anorexia—Prednisone—multiple sclerosis	0.000341	0.0011	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—PTPRC—multiple sclerosis	0.00034	0.00159	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—TNFAIP3—multiple sclerosis	0.00034	0.00159	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—TYK2—multiple sclerosis	0.00034	0.00159	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—POMC—multiple sclerosis	0.000339	0.00158	CbGpPWpGaD
Rifabutin—Anaemia—Methotrexate—multiple sclerosis	0.000338	0.00109	CcSEcCtD
Rifabutin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000338	0.00109	CcSEcCtD
Rifabutin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000338	0.00109	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HLA-DQB1—multiple sclerosis	0.000338	0.00158	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000336	0.00108	CcSEcCtD
Rifabutin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000336	0.00108	CcSEcCtD
Rifabutin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000333	0.00108	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—C4A—multiple sclerosis	0.000333	0.00156	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL7—multiple sclerosis	0.000333	0.00156	CbGpPWpGaD
Rifabutin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000333	0.00107	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—CCL2—multiple sclerosis	0.000331	0.00155	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—GPC5—multiple sclerosis	0.000331	0.00154	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—MAPK1—multiple sclerosis	0.000329	0.00154	CbGpPWpGaD
Rifabutin—Leukopenia—Methotrexate—multiple sclerosis	0.000328	0.00106	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000326	0.00105	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CD86—multiple sclerosis	0.000326	0.00152	CbGpPWpGaD
Rifabutin—Asthenia—Triamcinolone—multiple sclerosis	0.000325	0.00105	CcSEcCtD
Rifabutin—Abdominal pain—Betamethasone—multiple sclerosis	0.000325	0.00105	CcSEcCtD
Rifabutin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000325	0.00105	CcSEcCtD
Rifabutin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000325	0.00105	CcSEcCtD
Rifabutin—Body temperature increased—Betamethasone—multiple sclerosis	0.000325	0.00105	CcSEcCtD
Rifabutin—Asthenia—Methylprednisolone—multiple sclerosis	0.000324	0.00104	CcSEcCtD
Rifabutin—Insomnia—Prednisone—multiple sclerosis	0.000323	0.00104	CcSEcCtD
Rifabutin—Paraesthesia—Prednisone—multiple sclerosis	0.000321	0.00104	CcSEcCtD
Rifabutin—Pruritus—Triamcinolone—multiple sclerosis	0.00032	0.00103	CcSEcCtD
Rifabutin—Pruritus—Methylprednisolone—multiple sclerosis	0.000319	0.00103	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—PDCD1—multiple sclerosis	0.000319	0.00149	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD40LG—multiple sclerosis	0.000319	0.00149	CbGpPWpGaD
Rifabutin—Convulsion—Methotrexate—multiple sclerosis	0.000317	0.00102	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CD8A—multiple sclerosis	0.000316	0.00147	CbGpPWpGaD
Rifabutin—Dyspepsia—Prednisone—multiple sclerosis	0.000315	0.00102	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—LINGO1—multiple sclerosis	0.000314	0.00147	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL7R—multiple sclerosis	0.000313	0.00146	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	0.000313	0.00146	CbGpPWpGaD
Rifabutin—Arthralgia—Methotrexate—multiple sclerosis	0.000312	0.00101	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—multiple sclerosis	0.000312	0.00101	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—multiple sclerosis	0.000312	0.00101	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CD4—multiple sclerosis	0.000311	0.00145	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—MAPK1—multiple sclerosis	0.000311	0.00145	CbGpPWpGaD
Rifabutin—Decreased appetite—Prednisone—multiple sclerosis	0.000311	0.001	CcSEcCtD
Rifabutin—Rash—Prednisolone—multiple sclerosis	0.00031	0.001	CcSEcCtD
Rifabutin—Dermatitis—Prednisolone—multiple sclerosis	0.00031	0.001	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00031	0.000998	CcSEcCtD
Rifabutin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000309	0.000996	CcSEcCtD
Rifabutin—Headache—Prednisolone—multiple sclerosis	0.000308	0.000994	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—CD28—multiple sclerosis	0.000306	0.00143	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HLA-B—multiple sclerosis	0.000304	0.00142	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP27B1—multiple sclerosis	0.000303	0.00141	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP24A1—multiple sclerosis	0.000303	0.00141	CbGpPWpGaD
Rifabutin—Confusional state—Methotrexate—multiple sclerosis	0.000301	0.000972	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—CCR2—multiple sclerosis	0.0003	0.0014	CbGpPWpGaD
Rifabutin—Feeling abnormal—Prednisone—multiple sclerosis	0.000295	0.00095	CcSEcCtD
Rifabutin—Asthenia—Betamethasone—multiple sclerosis	0.000295	0.00095	CcSEcCtD
Rifabutin—Asthenia—Dexamethasone—multiple sclerosis	0.000295	0.00095	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000293	0.000944	CcSEcCtD
Rifabutin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000292	0.000943	CcSEcCtD
Rifabutin—Nausea—Prednisolone—multiple sclerosis	0.000292	0.000943	CcSEcCtD
Rifabutin—Pruritus—Dexamethasone—multiple sclerosis	0.00029	0.000937	CcSEcCtD
Rifabutin—Pruritus—Betamethasone—multiple sclerosis	0.00029	0.000937	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—multiple sclerosis	0.00029	0.000936	CcSEcCtD
Rifabutin—Vomiting—Triamcinolone—multiple sclerosis	0.000288	0.000928	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CBLB—multiple sclerosis	0.000288	0.00134	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000288	0.00134	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000288	0.00134	CbGpPWpGaD
Rifabutin—Vomiting—Methylprednisolone—multiple sclerosis	0.000287	0.000926	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—IL6—multiple sclerosis	0.000286	0.00133	CbGpPWpGaD
Rifabutin—Rash—Triamcinolone—multiple sclerosis	0.000285	0.00092	CcSEcCtD
Rifabutin—Dermatitis—Triamcinolone—multiple sclerosis	0.000285	0.000919	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—multiple sclerosis	0.000285	0.000919	CcSEcCtD
Rifabutin—Rash—Methylprednisolone—multiple sclerosis	0.000285	0.000918	CcSEcCtD
Rifabutin—HSP90B1—Immune System—IL2RA—multiple sclerosis	0.000285	0.00133	CbGpPWpGaD
Rifabutin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000284	0.000917	CcSEcCtD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000284	0.00132	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000284	0.00132	CbGpPWpGaD
Rifabutin—Headache—Triamcinolone—multiple sclerosis	0.000283	0.000914	CcSEcCtD
Rifabutin—Headache—Methylprednisolone—multiple sclerosis	0.000283	0.000912	CcSEcCtD
Rifabutin—Abdominal pain—Prednisone—multiple sclerosis	0.000283	0.000912	CcSEcCtD
Rifabutin—Body temperature increased—Prednisone—multiple sclerosis	0.000283	0.000912	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HLA-A—multiple sclerosis	0.000281	0.00131	CbGpPWpGaD
Rifabutin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000281	0.000906	CcSEcCtD
Rifabutin—Diarrhoea—Betamethasone—multiple sclerosis	0.000281	0.000906	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—IFNB1—multiple sclerosis	0.000277	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GPC5—multiple sclerosis	0.000277	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TAGAP—multiple sclerosis	0.000272	0.00127	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000272	0.000878	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—multiple sclerosis	0.00027	0.000872	CcSEcCtD
Rifabutin—HSP90AA1—Influenza Infection—TGFB1—multiple sclerosis	0.000269	0.00126	CbGpPWpGaD
Rifabutin—Nausea—Triamcinolone—multiple sclerosis	0.000269	0.000867	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—multiple sclerosis	0.000268	0.000865	CcSEcCtD
Rifabutin—Nausea—Methylprednisolone—multiple sclerosis	0.000268	0.000865	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—multiple sclerosis	0.000266	0.000859	CcSEcCtD
Rifabutin—Hypersensitivity—Prednisone—multiple sclerosis	0.000263	0.00085	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—multiple sclerosis	0.000263	0.000848	CcSEcCtD
Rifabutin—HSP90AA1—NRF2 pathway—TGFB1—multiple sclerosis	0.000262	0.00122	CbGpPWpGaD
Rifabutin—Vomiting—Betamethasone—multiple sclerosis	0.000261	0.000842	CcSEcCtD
Rifabutin—Vomiting—Dexamethasone—multiple sclerosis	0.000261	0.000842	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—multiple sclerosis	0.00026	0.000838	CcSEcCtD
Rifabutin—Rash—Dexamethasone—multiple sclerosis	0.000259	0.000835	CcSEcCtD
Rifabutin—Rash—Betamethasone—multiple sclerosis	0.000259	0.000835	CcSEcCtD
Rifabutin—Dermatitis—Dexamethasone—multiple sclerosis	0.000259	0.000834	CcSEcCtD
Rifabutin—Dermatitis—Betamethasone—multiple sclerosis	0.000259	0.000834	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000258	0.000832	CcSEcCtD
Rifabutin—HSP90B1—Immune System—TLR4—multiple sclerosis	0.000257	0.0012	CbGpPWpGaD
Rifabutin—Headache—Betamethasone—multiple sclerosis	0.000257	0.00083	CcSEcCtD
Rifabutin—Headache—Dexamethasone—multiple sclerosis	0.000257	0.00083	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HLA-DRB1—multiple sclerosis	0.000257	0.0012	CbGpPWpGaD
Rifabutin—Asthenia—Prednisone—multiple sclerosis	0.000257	0.000827	CcSEcCtD
Rifabutin—Pain—Methotrexate—multiple sclerosis	0.000256	0.000824	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—MX1—multiple sclerosis	0.000255	0.00119	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—multiple sclerosis	0.000253	0.00118	CbGpPWpGaD
Rifabutin—Pruritus—Prednisone—multiple sclerosis	0.000253	0.000816	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—HLA-DRA—multiple sclerosis	0.000247	0.00115	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ICAM1—multiple sclerosis	0.000247	0.00115	CbGpPWpGaD
Rifabutin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000246	0.000794	CcSEcCtD
Rifabutin—Diarrhoea—Prednisone—multiple sclerosis	0.000245	0.000789	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000244	0.000788	CcSEcCtD
Rifabutin—Nausea—Betamethasone—multiple sclerosis	0.000244	0.000787	CcSEcCtD
Rifabutin—Nausea—Dexamethasone—multiple sclerosis	0.000244	0.000787	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—IL6—multiple sclerosis	0.000239	0.00112	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—S1PR1—multiple sclerosis	0.000238	0.00111	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD80—multiple sclerosis	0.000238	0.00111	CbGpPWpGaD
Rifabutin—Body temperature increased—Methotrexate—multiple sclerosis	0.000236	0.000762	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—multiple sclerosis	0.000236	0.000762	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—MAPK1—multiple sclerosis	0.000235	0.0011	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NOD1—multiple sclerosis	0.000233	0.00109	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GPC5—multiple sclerosis	0.000232	0.00108	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—RRM1—multiple sclerosis	0.00023	0.00107	CbGpPWpGaD
Rifabutin—Vomiting—Prednisone—multiple sclerosis	0.000227	0.000733	CcSEcCtD
Rifabutin—Rash—Prednisone—multiple sclerosis	0.000225	0.000727	CcSEcCtD
Rifabutin—Dermatitis—Prednisone—multiple sclerosis	0.000225	0.000726	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—MALT1—multiple sclerosis	0.000225	0.00105	CbGpPWpGaD
Rifabutin—Headache—Prednisone—multiple sclerosis	0.000224	0.000722	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—IRF5—multiple sclerosis	0.000221	0.00103	CbGpPWpGaD
Rifabutin—Hypersensitivity—Methotrexate—multiple sclerosis	0.00022	0.00071	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—MAPK1—multiple sclerosis	0.000219	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CD86—multiple sclerosis	0.000218	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—MAPK1—multiple sclerosis	0.000216	0.00101	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RPL5—multiple sclerosis	0.000215	0.001	CbGpPWpGaD
Rifabutin—Asthenia—Methotrexate—multiple sclerosis	0.000214	0.000691	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—TYK2—multiple sclerosis	0.000213	0.000996	CbGpPWpGaD
Rifabutin—Nausea—Prednisone—multiple sclerosis	0.000212	0.000685	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—IRF8—multiple sclerosis	0.000212	0.000988	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFIH1—multiple sclerosis	0.000212	0.000988	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-G—multiple sclerosis	0.000212	0.000988	CbGpPWpGaD
Rifabutin—Pruritus—Methotrexate—multiple sclerosis	0.000211	0.000682	CcSEcCtD
Rifabutin—HSP90AA1—Disease—SLC11A1—multiple sclerosis	0.000206	0.000962	CbGpPWpGaD
Rifabutin—Diarrhoea—Methotrexate—multiple sclerosis	0.000204	0.000659	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—HLA-B—multiple sclerosis	0.000204	0.000951	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RGS1—multiple sclerosis	0.000202	0.000945	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—TYK2—multiple sclerosis	0.000201	0.000936	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.0002	0.000935	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TNFAIP3—multiple sclerosis	0.000198	0.000925	CbGpPWpGaD
Rifabutin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000195	0.000909	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GPR65—multiple sclerosis	0.000192	0.000896	CbGpPWpGaD
Rifabutin—Vomiting—Methotrexate—multiple sclerosis	0.00019	0.000613	CcSEcCtD
Rifabutin—Rash—Methotrexate—multiple sclerosis	0.000188	0.000608	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—multiple sclerosis	0.000188	0.000607	CcSEcCtD
Rifabutin—HSP90B1—Immune System—IFNG—multiple sclerosis	0.000188	0.000877	CbGpPWpGaD
Rifabutin—Headache—Methotrexate—multiple sclerosis	0.000187	0.000604	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CD4—multiple sclerosis	0.000181	0.000847	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—IL6—multiple sclerosis	0.000181	0.000844	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000179	0.000834	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD28—multiple sclerosis	0.000178	0.000832	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000178	0.000831	CbGpPWpGaD
Rifabutin—Nausea—Methotrexate—multiple sclerosis	0.000177	0.000572	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—STAT3—multiple sclerosis	0.000176	0.000821	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL13—multiple sclerosis	0.000176	0.00082	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCR1—multiple sclerosis	0.000176	0.00082	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTPRC—multiple sclerosis	0.000175	0.000817	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CCR2—multiple sclerosis	0.000175	0.000817	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—TLR4—multiple sclerosis	0.000173	0.000806	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-DPB1—multiple sclerosis	0.000169	0.00079	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—IL6—multiple sclerosis	0.000168	0.000786	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP9—multiple sclerosis	0.000168	0.000784	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL1B—multiple sclerosis	0.000167	0.000782	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL2—multiple sclerosis	0.000167	0.000779	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IL6—multiple sclerosis	0.000166	0.000776	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD28—multiple sclerosis	0.000165	0.000768	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD40—multiple sclerosis	0.000163	0.000759	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ITGA4—multiple sclerosis	0.000163	0.000759	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNB1—multiple sclerosis	0.000161	0.000754	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTLA4—multiple sclerosis	0.00016	0.000748	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—MAPK1—multiple sclerosis	0.00016	0.000747	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CD80—multiple sclerosis	0.000159	0.000743	CbGpPWpGaD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000158	0.000737	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TYK2—multiple sclerosis	0.000152	0.000711	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00015	0.000701	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000143	0.000668	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000143	0.000668	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—VCAM1—multiple sclerosis	0.000142	0.000661	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-DQA1—multiple sclerosis	0.000141	0.000659	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—STAT3—multiple sclerosis	0.00014	0.000656	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000139	0.00065	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000139	0.000648	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000136	0.000635	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MAPK1—multiple sclerosis	0.000136	0.000634	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—TYK2—multiple sclerosis	0.000134	0.000628	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-DQB1—multiple sclerosis	0.000132	0.000616	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—BCHE—multiple sclerosis	0.000132	0.000616	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.00013	0.000605	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.00013	0.000605	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—MAPK1—multiple sclerosis	0.000128	0.000596	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD86—multiple sclerosis	0.000127	0.000594	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL3—multiple sclerosis	0.000125	0.000584	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD40LG—multiple sclerosis	0.000125	0.000582	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD8A—multiple sclerosis	0.000123	0.000576	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IL6—multiple sclerosis	0.000123	0.000574	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000122	0.000568	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CD4—multiple sclerosis	0.000122	0.000568	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTGER4—multiple sclerosis	0.00012	0.000562	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—multiple sclerosis	0.00012	0.00056	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-B—multiple sclerosis	0.000119	0.000554	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PGR—multiple sclerosis	0.000119	0.000554	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD86—multiple sclerosis	0.000117	0.000548	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCR3—multiple sclerosis	0.000116	0.000543	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CD28—multiple sclerosis	0.000115	0.000538	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCR2—multiple sclerosis	0.000113	0.000528	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2RA—multiple sclerosis	0.000111	0.000519	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-A—multiple sclerosis	0.00011	0.000513	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—STAT3—multiple sclerosis	0.000107	0.000498	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CNR1—multiple sclerosis	0.000104	0.000487	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6—multiple sclerosis	0.000104	0.000487	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CCR5—multiple sclerosis	0.000104	0.000486	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—multiple sclerosis	0.000103	0.000479	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HLA-A—multiple sclerosis	0.000101	0.000474	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TLR4—multiple sclerosis	0.0001	0.000469	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-DRB1—multiple sclerosis	0.0001	0.000469	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	0.0001	0.000468	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TGFB1—multiple sclerosis	9.88e-05	0.000461	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—multiple sclerosis	9.81e-05	0.000458	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK1—multiple sclerosis	9.69e-05	0.000452	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ICAM1—multiple sclerosis	9.63e-05	0.00045	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APOE—multiple sclerosis	9.47e-05	0.000442	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL10—multiple sclerosis	9.4e-05	0.000439	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD80—multiple sclerosis	9.27e-05	0.000433	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—multiple sclerosis	9.22e-05	0.000431	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—multiple sclerosis	9.17e-05	0.000428	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SRM—multiple sclerosis	9.04e-05	0.000422	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK1—multiple sclerosis	8.97e-05	0.000419	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD80—multiple sclerosis	8.56e-05	0.0004	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK1—multiple sclerosis	8.56e-05	0.000399	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—POMC—multiple sclerosis	8.38e-05	0.000391	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CD86—multiple sclerosis	8.22e-05	0.000384	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL5—multiple sclerosis	8.09e-05	0.000378	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOE—multiple sclerosis	7.93e-05	0.00037	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TYK2—multiple sclerosis	7.83e-05	0.000366	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SPP1—multiple sclerosis	7.49e-05	0.00035	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—multiple sclerosis	7.44e-05	0.000348	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNG—multiple sclerosis	7.33e-05	0.000342	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCR5—multiple sclerosis	7.29e-05	0.00034	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TYK2—multiple sclerosis	7.23e-05	0.000337	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2RA—multiple sclerosis	7.18e-05	0.000335	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD4—multiple sclerosis	7.08e-05	0.000331	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SRM—multiple sclerosis	6.98e-05	0.000326	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—POMC—multiple sclerosis	6.81e-05	0.000318	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOE—multiple sclerosis	6.63e-05	0.00031	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—multiple sclerosis	6.57e-05	0.000307	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL1B—multiple sclerosis	6.54e-05	0.000305	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD4—multiple sclerosis	6.54e-05	0.000305	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—multiple sclerosis	6.51e-05	0.000304	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6.47e-05	0.000302	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	6.37e-05	0.000297	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	6.37e-05	0.000297	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.23e-05	0.000291	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALB—multiple sclerosis	6.21e-05	0.00029	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CD80—multiple sclerosis	6e-05	0.00028	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPC5—multiple sclerosis	5.83e-05	0.000272	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—POMC—multiple sclerosis	5.7e-05	0.000266	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL2—multiple sclerosis	5.57e-05	0.00026	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—multiple sclerosis	5.48e-05	0.000256	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TYK2—multiple sclerosis	5.06e-05	0.000236	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—multiple sclerosis	5.06e-05	0.000236	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK1—multiple sclerosis	4.98e-05	0.000233	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.92e-05	0.00023	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.92e-05	0.00023	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—RRM1—multiple sclerosis	4.83e-05	0.000225	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—multiple sclerosis	4.7e-05	0.00022	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—multiple sclerosis	4.69e-05	0.000219	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK1—multiple sclerosis	4.6e-05	0.000215	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.5e-05	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—multiple sclerosis	4.21e-05	0.000197	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—multiple sclerosis	3.99e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—multiple sclerosis	3.83e-05	0.000179	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.75e-05	0.000175	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.73e-05	0.000174	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—multiple sclerosis	3.54e-05	0.000165	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—multiple sclerosis	3.54e-05	0.000165	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—multiple sclerosis	3.29e-05	0.000154	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—multiple sclerosis	3.29e-05	0.000153	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK1—multiple sclerosis	3.22e-05	0.00015	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.22e-05	0.00015	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.93e-05	0.000137	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.77e-05	0.000129	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—multiple sclerosis	2.48e-05	0.000116	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.14e-05	9.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOE—multiple sclerosis	1.67e-05	7.79e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—POMC—multiple sclerosis	1.43e-05	6.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—multiple sclerosis	1.31e-05	6.1e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOE—multiple sclerosis	1.29e-05	6.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—POMC—multiple sclerosis	1.11e-05	5.16e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—multiple sclerosis	1.01e-05	4.71e-05	CbGpPWpGaD
